Jadelle® : Progesterone-only implant contraception

Estimated Duration: 
2 hours

Jadelle® is a long-acting reversible contraception (LARC) initially approved for use in the US in 1996.  Jadelle® is now approved in more than 44 countries and used by more than 3 million women worldwide.

By the end of the course you will be able to:

  • Advise women and men requesting contraception and enable them to make informed choices about managing their fertility.
  • Appropriately consult with and assess women who wish to use the Jadelle® implant.
  • Understand the composition and pharmacokinetics of the Jadelle® implant and potential drug interactions.
  • Explain the indications and contraindications, medical eligibility criteria, advantages and disadvantages, side effects and complications of Jadelle® implant use.
  • Understand the mode of action and contraceptive efficacy of implants.
  • Manage side effects of Jadelle® including bleeding problems.
  • Describe the management of an impalpable implant.


Once you have completed this short course and quiz, please click 'submit' where you will be taken to the results page. From here you can print your certificate for 2 hours of Continuing Professional Development points.


This content was created by Dr Orna McGinn, MRCGP (UK) DRCOG DFFP FRCNZGP in February 2017.

This course has been endorsed by The Pharmaceutical Society of New Zealand (PSNZ) and by The Royal New Zealand College of General Practitioners (RNZCGP) for CME credits for their General Practice Educational Programme (GPEP) and Continuing Professional Development (CPD) purposes, and the College of Nurses Aotearoa (NZ) for PD hours.


Sign in to start this course.

Sign in Register

(If you are not already a Goodfellow member click the Register button. It takes less than a minute and is completely free)